Nn9924-4437
Research payments
$2,556,861
Through program year 2025, $2,556,861 in research payments was reported against Nn9924-4437, across 18,106 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $491,773 | 108 |
| 2024 | Research | $293,123 | 1,910 |
| 2023 | Research | $702,202 | 3,762 |
| 2022 | Research | $490,072 | 6,715 |
| 2021 | Research | $527,294 | 4,752 |
| 2020 | Research | $52,399 | 859 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
6 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lily Chao Los Angeles, CA Named on 4,096 payments
- Matthew Benson Orlando, FL Named on 2,874 payments
- Silva Arslanian Pittsburgh, PA Named on 2,619 payments
- Kupper Wintergerst Louisville, KY Named on 518 payments
- Laura Akright Live Oak, TX Named on 508 payments
- Henry Rodriguez Mishawaka South Bend, IN Named on 412 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.